skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 4,185  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Cancers remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic Impact of Serum β[sub.2]-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients
Material Type:
Article
Add to My Research

Prognostic Impact of Serum β[sub.2]-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients

Cancers, 2024-01, Vol.16 (2) [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16020238

Full text available

2
Comment on Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. ICancers/I 2023, I15/I, 4081
Material Type:
Article
Add to My Research

Comment on Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. ICancers/I 2023, I15/I, 4081

Cancers, 2023-11, Vol.15 (23) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15235618

Full text available

3
Correlations between [[sup.68]Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [[sup.177]Lu]Lu-DOTA-TATE
Material Type:
Article
Add to My Research

Correlations between [[sup.68]Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [[sup.177]Lu]Lu-DOTA-TATE

Cancers, 2023-02, Vol.15 (4) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15041134

Full text available

4
Potential Therapeutic Improvements in Prostate Cancer Treatment Using Pencil Beam Scanning Proton Therapy with LET[sub.d] Optimization and Disease-Specific RBE Models
Material Type:
Article
Add to My Research

Potential Therapeutic Improvements in Prostate Cancer Treatment Using Pencil Beam Scanning Proton Therapy with LET[sub.d] Optimization and Disease-Specific RBE Models

Cancers, 2024-02, Vol.16 (4) [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16040780

Full text available

5
Correction: Zhang et al. Clinical Management of Low Anterior Resection Syndrome: Review of the Current Diagnosis and Treatment. ICancers/I 2023, I15/I, 5011
Material Type:
Article
Add to My Research

Correction: Zhang et al. Clinical Management of Low Anterior Resection Syndrome: Review of the Current Diagnosis and Treatment. ICancers/I 2023, I15/I, 5011

Cancers, 2024-01, Vol.16 (2) [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16020459

Full text available

6
New IN/I-Adducts of Thiadiazole and Thiazoline with Levoglucosenone and Evaluation of Their Significant Cytotoxic Activity
Material Type:
Article
Add to My Research

New IN/I-Adducts of Thiadiazole and Thiazoline with Levoglucosenone and Evaluation of Their Significant Cytotoxic Activity

Cancers, 2024-01, Vol.16 (1) [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16010216

Full text available

7
Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [[sup.177]Lu]Lu-DOTA-TATE or [[sup.177]Lu]Lu-DOTA-TATE and [[sup.90]Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center
Material Type:
Article
Add to My Research

Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [[sup.177]Lu]Lu-DOTA-TATE or [[sup.177]Lu]Lu-DOTA-TATE and [[sup.90]Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center

Cancers, 2023-11, Vol.15 (22) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15225466

Full text available

8
Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based K[sub.V]1.3 Inhibitors and Their Potential for Anticancer Activity. ICancers/I 2022, I14/I, 2595
Material Type:
Article
Add to My Research

Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based K[sub.V]1.3 Inhibitors and Their Potential for Anticancer Activity. ICancers/I 2022, I14/I, 2595

Cancers, 2023-05, Vol.15 (11) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15112925

Full text available

9
Preoperative Dose-Escalated Intensity-Modulated Radiotherapy in Patients with Retroperitoneal Soft-Tissue Sarcoma: Final Results of a Clinical Phase I/II Trial
Material Type:
Article
Add to My Research

Preoperative Dose-Escalated Intensity-Modulated Radiotherapy in Patients with Retroperitoneal Soft-Tissue Sarcoma: Final Results of a Clinical Phase I/II Trial

Cancers, 2023-05, Vol.15 (10) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15102747

Full text available

10
Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma and Cholangiocarcinoma
Material Type:
Article
Add to My Research

Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma and Cholangiocarcinoma

Cancers, 2022-12, Vol.15 (1) [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15010050

Full text available

11
The Current Role of Stereotactic Body Radiation Therapy
Material Type:
Article
Add to My Research

The Current Role of Stereotactic Body Radiation Therapy

Cancers, 2022-09, Vol.14 (18) [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers14184383

Full text available

12
‘The Reports of My Death Are Greatly Exaggerated’—Evaluating the Effect of Necrosis on IMGMT/I Promoter Methylation Testing in High-Grade Glioma
Material Type:
Article
Add to My Research

‘The Reports of My Death Are Greatly Exaggerated’—Evaluating the Effect of Necrosis on IMGMT/I Promoter Methylation Testing in High-Grade Glioma

Cancers, 2024-05, Vol.16 (10) [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16101906

Full text available

13
RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin α[sub.v]β[sub.3] Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. ICancers/I 2021, I13/I, 2780
Material Type:
Article
Add to My Research

RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin α[sub.v]β[sub.3] Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. ICancers/I 2021, I13/I, 2780

Cancers, 2024-05, Vol.16 (10) [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16101880

Full text available

14
Clinical [[sup.18]F]FSPG Positron Emission Tomography Imaging Reveals Heterogeneity in Tumor-Associated System x[sub.c][sup.−] Activity
Material Type:
Article
Add to My Research

Clinical [[sup.18]F]FSPG Positron Emission Tomography Imaging Reveals Heterogeneity in Tumor-Associated System x[sub.c][sup.−] Activity

Cancers, 2024-04, Vol.16 (7) [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16071437

Full text available

15
RETRACTED: Liu et al. Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images. ICancers/I 2023, I15/I, 4044
Material Type:
Article
Add to My Research

RETRACTED: Liu et al. Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images. ICancers/I 2023, I15/I, 4044

Cancers, 2024-01, Vol.16 (3) [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16030493

Full text available

16
The m[sup.7]G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling
Material Type:
Article
Add to My Research

The m[sup.7]G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling

Cancers, 2023-11, Vol.15 (22) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15225454

Full text available

17
Reply to Chen, A.; Zhang, X. Comment on “Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. ICancers/I 2023, I15/I, 4081”
Material Type:
Article
Add to My Research

Reply to Chen, A.; Zhang, X. Comment on “Golčić et al. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours. ICancers/I 2023, I15/I, 4081”

Cancers, 2023-11, Vol.15 (23) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15235619

Full text available

18
Integrins Can Act as Suppressors of Ras-Mediated Oncogenesis in the IDrosophila/I Wing Disc Epithelium
Material Type:
Article
Add to My Research

Integrins Can Act as Suppressors of Ras-Mediated Oncogenesis in the IDrosophila/I Wing Disc Epithelium

Cancers, 2023-11, Vol.15 (22) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15225432

Full text available

19
MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. INat. Med./I 2023, I29/I, 115–126
Material Type:
Article
Add to My Research

MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. INat. Med./I 2023, I29/I, 115–126

Cancers, 2023-09, Vol.15 (18) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15184476

Full text available

20
Targeting IMET/I Amplification: Opportunities and Obstacles in Therapeutic Approaches
Material Type:
Article
Add to My Research

Targeting IMET/I Amplification: Opportunities and Obstacles in Therapeutic Approaches

Cancers, 2023-09, Vol.15 (18) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15184552

Full text available

Results 1 - 20 of 4,185  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait